Engineering the Hematopoietic System to Treat Non-Hematological Disorders
Explore how the hematopoietic system can be engineered to produce, secrete, and deliver therapeutic proteins to multiple organs—including the central nervous system—with Dr. Natalia Gomez-Ospina of Stanford University. This webinar was hosted by LabRoots scientific social network and sponsored by STEMCELL Technologies.
Publish Date:
February 03, 2020
Related Multimedia
-
CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells
Publish Date: June 26, 2018 -
Gene Targeting in Hematopoietic Stem Cells for Basic and Translational Research
Publish Date: November 28, 2018 -
Optimized Workflows for High-Efficiency Genome Editing in Stem and Primary Cell Types
Publish Date: September 09, 2019
Explore Our Products
-
Serum-free medium for culture and expansion of hematopoietic cells -
Methylcellulose-based medium with recombinant cytokines for human cells -
STEMdiff™ Microglia Differentiation Kit
Differentiation kit for the generation of microglia precursors from human ES and iPS cell-derived hematopoietic progenitor cells -
STEMdiff™ Microglia Maturation Kit
Maturation kit for the generation of microglia from human ES and iPS cell-derived microglia precursors
